UCSF finding suggests mechanism of experimental cancer drug, hinting at broader application for the drug, a modified cold virus UC San Francisco researchers may have discovered why the experimental anti-cancer drug Onyx-015 works more broadly than had been expected, a finding that could solidify and expand use of the drug and which reveals a potential new target for therapy that could prompt the development of other cancer drugs.
Onyx Pharmaceuticals, Inc.
Contact: Jennifer O'Brien
University of California, San Francisco
Message posted by: Wouter Kalle